The Medicines Company (MDCO) vs. Hedge Fund Favorites in 2019
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly...
Posts Tagged ‘NASDAQ:MDCO’
Hedge Funds Hit The Bullseye With This Stock Pick
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms...
Hedge Funds Have Never Been This Bullish On The Medicines Company (MDCO)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and...
Did Hedge Funds Drop The Ball On Medicines Company (MDCO)?
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors...
Hedge Fund and Insider Trading News: The Children’s Investment Fund, JDP Capital Management, Standard Motor Products, Inc. (SMP), Chembio Diagnostics Inc (CEMI), and More
Investors Resist Cashback Offer from Hohn’s TCI Fund (The Telegraph) The majority of investors in The Children’s Investment Fund (TCI), the British...
Did Hedge Funds Drop The Ball On The Medicines Company (MDCO) ?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors...
Hedge Fund and Insider Trading News: Eddie Lampert, Starboard Value LP, Elliott Management, Hartford Financial Services Group (HIG), The Medicines Company (MDCO), and More
Elliott’s U.K. Fixer-Upper Gets Another Lift (Bloomberg) For a company owner, a clean sale is usually preferable to the rigmarole of going public...
Hedge Fund and Insider Trading News: David Tepper, GMT Capital, Cosmos Holdings Inc (COSM), Strongbridge Biopharma PLC (SBBP), Sequential Brands Group Inc (SQBG), and More
David Tepper Says He’s Buying Stocks After Market’s Worst Week in a Decade (CNBC) Hedge fund manager David Tepper said Monday he is buying some stocks...
Is The Medicines Company (MDCO) A Good Stock To Buy?
A market correction in the fourth quarter, spurred by a number of global macroeconomic concerns and rising interest rates ended up having a negative impact...
Hedge Fund and Insider Trading News: Jonathan Litt, Mike Novogratz, The Medicines Company (MDCO), Checkpoint Therapeutics Inc (CKPT), Koppers Holdings Inc. (KOP), and More
Activist Investor Litt Renews Call for Saks Fifth Avenue Sale (Reuters) Nov 28 (Reuters) – Activist investor Jonathan Litt on Wednesday renewed...
Sarissa Capital’s Alex Denner Bullish on Biogen (BIIB)
Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr. Alexander...
Market Movers Today: Tenax Therapeutics Inc (TENX), Overstock.com Inc (OSTK), Box Inc (BOX), Patterson Companies, Inc. (PDCO), and More
Tenax Therapeutics Inc (NASDAQ:TENX) (Benzinga) Tenax Therapeutics Inc shares surged 140.5 percent to $ 11.16 as the company reported the publication...
This Fund’s Picks Gained 200% In A Year And Why No One Knows About It
You probably haven’t heard of Alex Denner‘s Sarissa Capital Management, which is a shame, as the fund is coming off a first-quarter in which...
13G Filing: Partner Fund Management and Medicines Co (MDCO)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc. (NASDAQ:AMGN), Esperion Therapeutics...
Hedge Funds Are Betting On The Medicines Company (MDCO)
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research...
Movers In Biotech: Cellectar Biosciences Inc (CLRB) And The Medicines Company (MDCO)
We’ve had another big day in biotech, and a number of companies have moved on news and fundamental developments. The political influence is starting...
Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments. This means that retail investors can...
Decsontructing The Latest The Medicines Company (MDCO) Release
The Medicines Company (NASDAQ:MDCO) just put out topline from its lead cholesterol trial, and the company has jumped on the back of the data. The release...
Why Yum, Booz Allen Hamilton, Alnylam, and More Are in the Spotlight
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark. On one hand, there will likely be strong resistance...
Gartner Inc. (IT), Signet Jewelers (SIG), and WPX Energy (WPG) Among the Companies Reporting Notable Insider Trading Activity
While Securities and Exchange Commission rules require executives, directors and other insiders to report purchases or sales in their own company’s...
Is The Medicines Company (MDCO) A Good Stock To Buy?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Micron and Anadarko Petroleum, have not done well during...
The Medicines Company (MDCO) and Alnylam Pharmaceuticals Inc. (ALNY)’s Positive Phase I Results Support Hedge Funds’ Confidence in These Companies
On August 30, The Medicines Company (NASDAQ:MDCO) and Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced positive initial results from their ongoing...
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO)
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois. The hedge fund is considered as an activist due to activist...
TrovaGene Inc (TROV) Sees Bridger Management Buy More Shares; Other Stocks Roberto Mignone Loves
Roberto Mignone‘s Bridger Management is a fund with around $2.0 billion in assets, one that is focused on healthcare stocks, which represent nearly...
The Medicines Company (MDCO), TG Therapeutics Inc (TGTX): Bridger Management & Ra Capital Management Taking Plunge
In the last few days, we have seen a lot of capital from funds that we track getting shifted to pharmaceutical stocks and no it’s not just sector specific...
Point State Capital Boosts its Stake in The Medicines Company (MDCO) to 7%
Led by Sean Cullinan, Point State Capital revealed a significantly increased position in The Medicines Company (NASDAQ:MDCO). The updated position...
Hedge Funds Are Betting On United Therapeutics Corporation (UTHR)
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge...
The Medicines Company (MDCO), United Therapeutics Corporation (UTHR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
In the eyes of many investors, hedge funds are perceived as bloated, outdated financial vehicles of a forgotten age. Although there are In excess of 8...
Cubist Pharmaceuticals Inc (CBST): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time. Although there...
Hedge Funds Aren’t Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore
Is Amarin Corporation plc (ADR) (NASDAQ:AMRN) a buy? In the financial world, there are many metrics shareholders can use to track their holdings. A duo...
The Medicines Company (MDCO), Merck & Co., Inc. (MRK), Baxter International Inc. (BAX): Three Reasons to Like This Critical Care Company
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37....
The Medicines Company (MDCO), AstraZeneca plc (ADR) (AZN): A Small-Cap Pharmaceutical Company With 2014 in Its Sights
A few months back, Barron’s featured an intriguing pharmaceutical company that goes by the name The Medicines Company (NASDAQ:MDCO). This stock...
Taro Pharmaceutical Industries Ltd. (TARO): Insiders Aren’t Crazy About It
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds’ portfolio at the end of March. TARO investors should pay attention to an increase...
Pipeline Probe: Alnylam Pharmaceuticals, Inc. (ALNY)
Shares of biotech Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) have soared over 160% in the past year. The company’s a leader in developing drugs...
Is United Therapeutics Corporation (UTHR) Going to Burn These Hedge Funds?
United Therapeutics Corporation (NASDAQ:UTHR) shareholders have witnessed a decrease in hedge fund interest of late. If you’d ask most investors...
Should You Buy The Medicines Company (MDCO)?
The Medicines Company (NASDAQ:MDCO) has experienced an increase in hedge fund sentiment recently. At the moment, there are a multitude of metrics investors...
Amarin Corporation plc (ADR) (AMRN): What’s The Smart Money Think?
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 19 hedge funds’ portfolio at the end of March. AMRN shareholders have witnessed a decrease in...
The Medicines Company (MDCO): Is There a Future for Small Pharma?
Small pharma is fighting an uphill battle. Fortunately, this is precisely what inspires a lot of companies to reach for the heavens. Unfortunately, the...
Hedge Funds Are Crazy About The Medicines Company (NASDAQ:MDCO)
The Medicines Company (NASDAQ:MDCO) shareholders have witnessed an increase in activity from the world’s largest hedge funds lately. According to...
3 Earning Results that Could Lead to a Long-Term Trend Higher: The Home Depot, Inc. (HD) and More
Earnings and earning-related news is the number one catalyst for stock movement. A strong quarter can dictate the direction of a stock for the following...
